Back

Discussant review - VICTORION-Difference

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: HOT LINE 4 Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail
BaxHTN – Efficacy and safety of the aldosterone synthase inhibitor baxdrostat in patients with uncontrolled or resistant hypertension
Professor B. Williams (London, GB)
Slides Video
Presentation thumbnail
Discussant review - BaxHTN
Professor T. Guzik (Edinburgh, GB)
Slides Video
Presentation thumbnail
Panel discussion - BaxHTN
Presentation thumbnail
KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk
Doctor N. Pagidipati (Durham, US)
Slides Video
Presentation thumbnail
Discussant review - KARDIA-3
Professor M. Tomaszewski (Manchester, GB)
Slides Video

Access the full session

Session thumbnail
HOT LINE 4
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Ask the Trialists - VICTORION
thumbnail
Congress Session
Strategies to reach LDL-C goals in patients with high or very high CV risk: what's new for inclisiran?
thumbnail
Congress Session
Refining efficacy and safety of lipid-lowering pharmacotherapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources